Nasopharyngeal Type-I Interferon for Immediately Available Prophylaxis Against Emerging Respiratory Viral Infections

In addition to SARS-CoV-2 and its variants, emerging viruses that cause respiratory viral infections will continue to arise. Increasing evidence suggests a delayed, possibly suppressed, type 1 interferon (IFN-I) response occurs early during COVID-19 and other viral respiratory infections such as SAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Amos C., Jeong, Yunjin, Lee, Sumin, Jang, Haewook, Zheng, Allen, Kwon, Sunghoon, Repine, John E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170395/
https://www.ncbi.nlm.nih.gov/pubmed/34093548
http://dx.doi.org/10.3389/fimmu.2021.660298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170395/
https://www.ncbi.nlm.nih.gov/pubmed/34093548
http://dx.doi.org/10.3389/fimmu.2021.660298

Ejemplares similares